1-METHOXY-3-(3-METHOXYPROPOXY)PROPANE, 95%, 5g

2,4-Dichloro-5-(trifluoromethyl)pyrimidine>98.0%(GC)1g

1-phenyl-5-[(pyrimidin-2-ylsulfanyl)methyl]-1H-1,2,3-triazole-4-carboxylic acid, 95.0%, 250mg

1,1-cyclobutanedicarboxylic acid, min. 98%, 5 g, plastic packaging.

N-(3,5-Difluorobenzyl)-N-methylamine, 97%, 250mg

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-6-(trifluoromethyl)pyridin-2-amine, 1g

(2S,4R)-1-((S)-2-Amino-3,3-dimethylbutanoyl)-4-hydroxy-N-((S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)pyrrolidine-2-carboxamide, 97%, 1g

1-Nitro-4-phenoxybenzene, 95.0%, 1g

2,2-Bis(4-glycidyloxyphenyl)propane>85.0%(GC)25g

4-Amino-1,3-dihydro-2H-benzimidazol-2-one, 97.0%, 1g

METHYL 3-CHLORO-5-FLUORO-2-METHYLBENZOATE, 95.0%, 1g

2 H -Chromene-3-carbaldehyde, 95.0%, 100mg

Paliperidone Palmitate>98.0%(HPLC)(T)100mg